Australian researchers for global tech company IBM have applied machine learning to identify proteins in blood that can predict Alzheimer’s disease risk.
Australian company Actinogen Medical is developing a new drug — Xanamem — that blocks the excess production of stress hormone cortisol in Alzheimer’s sufferers, offering a potential treatment for the disease.
"There's an app for that" is a cliche, and the phrase "ageing population" often turns up in political discourse. But even if there's a person with dementia in your family, would you have thought of an app that can make their home more accessible for them?
Agreed 100%.The double-speak hidden inside the Roy Morgan CEO statement "The best way to reduce the high level of labour[…]
Is it possible to use Arm cores in the new supercomputer? If a vendor could make a few hundred thousand[…]
So some truth about the availability of work is starting to emerge.16.7% unable to earn the income that they need.That[…]
NBN are so bad at what they do. Missed appointments are a given in nearly all installations, and just a[…]
Yes indeed, but that pre-supposes the existence of executives who a) actually understand a business model of revenue & profit[…]